Early View: Sustained Virologic Response with IFN, But Not DAAs Reduces the Risk of Hematologic Malignancies ow.ly/IXYL50uFt3c #VisualAbstract #HCV #SVR #AASLDjournals Gyongyi Szabo George Ioannou

Early View: Mortality Risk Detected by Atherosclerotic Cardiovascular Disease Score in Patients With Nonalcoholic Fatty Liver Disease ow.ly/a3pk50uFtaA #VisualAbstract #Cardiology #NAFLD #NASH #AASLDjournals Pegah Golabi Mehmet Sayiner James Paik Gyongyi Szabo

The latest #VisualAbstract from Vincent Chen in Hepatology Communications: Body Composition and Genetic Lipodystrophy Risk Score Associate With Nonalcoholic Fatty Liver Disease and Liver Fibrosis ow.ly/Ld2i50uP7BV Gyongyi Szabo #AASLDjournals

Liver‐Targeted Toll‐Like Receptor 7 Agonist Combined With Entecavir Promotes a Functional Cure in the Woodchuck Model of Hepatitis B Virus ow.ly/Dl9550v23eX #HBV #HepatitisB #entecavir #woodchuck #VisualAbstract #AASLDjournals Gyongyi Szabo

A Tweet about Twitter.... Da & colleagues published a novel study on #Twitter trends in Hepatology Communications ow.ly/2Hje50v2Pvr #HCV #HBV #NASH #HepC #HepB #NAFLD #VisualAbstract #AASLDjournals Gyongyi Szabo AASLD

Next #VisualAbstract from Nicole Kim MD, MPH in Hepatology Communications Hepatitis C Screening in an Underserved U.S. Cohort of Reproductive Age Women ow.ly/fRD150v4NWk #HCV #HepC #HepatitisC #AASLDjournals AASLD Gyongyi Szabo

AASLD / GHASSA Hepatology Connect program in Cape Town, South Africa. Gyongyi Szabo, MD, PhD, FAASLD [Gyongyi Szabo] delivers a presentation on Acute Liver Failure in Women. #AASLDglobal #AASLDOnTheRoad #HepConnect

Combatting the nasal swab shortage: hear how a clinical trial led by a team of BIDMC researchers is helping to boost production of 3D printed #COVID19 testing swabs, via CNBC: cnb.cx/2yvoDzy

BIDMC The Intrigue of Innate Immunity and Inflammation. Listen to Gyongyi Szabo here: bit.ly/361Zfhz Subscribe and review our Podcast on iTunes: apple.co/2Os0myK #Liver #ImmuneSystem #Healthcare #Findinggeniuspodcast #Health #Medicine #Biosciences

BIDMC’s Dan Barouch, MD, PhD, live on CNN this morning to discuss recent his team’s findings on #COVID19 vaccine prototypes.

The Liver Meeting® is going digital! Join us Nov. 13-16 for The Liver Meeting Digital Experience™ - same great content, same great colleagues and friends, brand new experience. Watch the message from AASLD President. bit.ly/3dJpdJT #TLMdX #LiverTwitter

We have a special delivery! Today, BIDMC received its first #COVID19 vaccine shipment! Our Pharmacy team received the packages and are preparing for distribution. For more vaccine information, be sure to visit our COVID-19 resources site: coronavirus.bilh.org/vaccine/

"This is a great step that has been taken to fight against COVID-19." Juan Cespedes, Emergency Department Technician, was the first #BIDMC staff member to receive the #vaccine against #COVID19 on Wednesday.

Vote for BIDMC’s Dan Barouch, MD, PhD, Barouch Lab, whose team helped develop the Johnson & Johnson #COVID19 vaccine. They've advanced to round 2 of #STATMadness, a competition among 64 labs for the coolest research. Vote here: bit.ly/3b4G2A7

We are looking for a Research Assistant II to join the Szabo lab at BIDMC. If you would like to contribute to groundbreaking science working towards curing liver disease through basic, translational and clinical research, please apply here: sjobs.brassring.com/TGnewUI/Search…

The launch of the Translational Research Hubs at BIDMC is here! Thank you to everyone who has helped get to this point. This is an exciting day for BIDMC and Research.

Excited to have our research community at BIDMC honored at the Massachusetts Health Council annual awards this afternoon! Gyongyi Szabo, chief academic officer, will accept on the team's behalf- congrats are due to everyone for their hard work!

Thank you to Harvard Medical School Dean George Q Daley for kicking off our 2022 BIDMC Research Retreat. #InSPIREdAtBIDMC #BIDMCResearch

Check out news on neutrophils in alcohol-associated liver disease authors.elsevier.com/a/1g89VcOnAN3y…